|
Map2k2 protein, mouse
|
C482129 |
|
|
Pyridinolcarbamate
|
D011727 |
[A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
] |
|
glycyl-tyrosyl-isoleucyl-glycyl-seryl-arginine
|
C061514 |
|
|
Pyridones
|
D011728 |
[Pyridine derivatives with one or more keto groups on the ring.
] |
|
endo16 protein, sea urchin
|
C061515 |
|
|
Pyridostigmine Bromide
|
D011729 |
[A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.
] |
|
histidylglycine
|
C061516 |
|
|
7,9-dimethylguanine
|
C061517 |
|
|
5-hydroperoxymethyl-2'-deoxyuridine
|
C061518 |
|
|
Braf protein, mouse
|
C482120 |
|
|
cybernins
|
C036580 |
|
|
5-formyl-2'-deoxyuridine
|
C061519 |
|
|
Zeo1 protein, S cerevisiae
|
C482121 |
|
|
cystine disulfoxide
|
C036581 |
|
|
glucuronosyl(1-4)-rhamnose
|
C036582 |
|
|
Braf protein, rat
|
C482123 |
|
|
lanatoside A
|
C036572 |
|
|
Rhok protein, rat
|
C496765 |
|
|
Pyrazoles
|
D011720 |
[Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
] |
|
poly(G,I).poly(C)
|
C036573 |
|
